Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas

85 participants · First posted Feb 5, 2014

European Stop Tyrosine Kinase Inhibitor Study

868 participants · First posted May 10, 2012

Dysregulated Tyrosine Kinase Signaling in Leukemia

30 participants · First posted Jan 13, 2006

Tyrosine(Premasol, Clinimix E 2.75/5, Aminosyn-PF 7%, Primene, Clinimix 2.75/5, Trophamine 10 %, Plenamine, Olimel, Prosol, Clinisol 15, Periolimel, Travasol 10)

C₉H₁₁NO₃

Bruton's tyrosine kinase inhibitor(TargetRx)

Inhibikase Therapeutics

United States

Exelixis, Inc.

United States

Regeneron Pharmaceuticals

United States

Nurix Therapeutics Presents Promising BTK Degrader Data at ASH 2024

Infection Risk With BTK Inhibitors Low, New CLL Study Finds

Update on the Efficacy of Venetoclax for Chronic Lymphocytic Leukemia